홈 › 크론병 › 뉴욕 › New York City

NY New York City의 크론병 임상 시험

크론병 관련 연구 35개가 New York City 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.

공식 연구 텍스트(영어)

연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

피험자 모집 중2상

New York Gastroenterology Associates - Upper East Side /ID# 281767, New York

18세 ~ 75세 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT07697456

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

피험자 모집 중1상

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
NYP/Weill Cornell Medical Center, New York

18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT03816345

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

피험자 모집 중3상

New York Gastroenterology Associates ( Site 0253), New York

전 연령 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06651281

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

피험자 모집 중3상

NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 5078), New York
Weill Cornell Medical College, New-York Presbyterian Hospital ( Site 5079), New York
New York Gastroenterology Associates ( Site 5013), New York

16세 ~ 80세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06430801

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

피험자 모집 중4상

New York Gastroenterology Associates, New York

18세 ~ 80세 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

피험자 모집 중2상

Northwell Health-Lenox Hill Hospital /ID# 265527, New York

18세 ~ 75세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06548542

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

피험자 모집 중3상

Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center, New York
Icahn School of Medicine at Mount Sinai, New York

2세 ~ 17세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05923073

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

피험자 모집 중2상

Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH), New York

18세 ~ 75세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06233461

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

피험자 모집 중3상

New York Gastroenterology Associates, New York

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

피험자 모집 중2/3상

Inflammatory Bowel Disease Center at NYU Langone, New York
Weill Cornell Medical College, New York
Lenox Hill Hospital, New York
외 1개

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07196722

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

피험자 모집 중3상

New York Gastroenterology Associates, New York

18세 ~ 70세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

피험자 모집 중3상

Manhattan Clinical Research, LLC-Site Number: 8400069, New York
NYU Langone Health-Site Number: 8400091, New York
Columbia University Medical Center-Site Number: 8400138, New York
외 2개

16세 ~ 80세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

피험자 모집 중3상

NYU Langone Health-Site Number: 8400091, New York
Weill Cornell Medicine - NewYork-Presbyterian Hospital-Site Number: 8400040, New York
New York Gastroenterology Associates-Site Number: 8400009, New York

16세 ~ 80세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07184944

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

피험자 모집 중3상

Icahn School of Medicine at Mount Sinai /ID# 254880, New York

2세 ~ 17세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT05995353

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

피험자 모집 중3상

Icahn School of Medicine at Mount Sinai, New York

2세 ~ 19세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT04844606

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

피험자 모집 중4상

NYU Langone Health, New York

18세 ~ 70세 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06045754

Standardized Microbiota Transplant Therapy in Crohn's Disease

피험자 모집 중2상

NYU Langone Health, New York

18세 ~ 89세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06631586

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

피험자 모집 중3상

New York Gastroenterology Associates, New York

18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07577843

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

피험자 모집 중3상

Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC), New York
Icahn School of Medicine at Mount Sinai, New York
Columbia University Medical Center/New York Presbyterian, New York

2세 ~ 17세 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT05509777